CONCURRENT SESSION: Moderated Poster Session 1: Prostate Cancer

EDT

Moderators: Daniel Lee, MD, Jeffrey Tomaszewski, MD

MP1-01

Comparative Outcomes of Salvage Retzius-sparing Versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series
Keith Kowalczyk

MP1-02

Does Deferred Prostatectomy for Grade Group 1 and 2 Increase Risk of Adverse Pathology?
Cheyenne Williams

MP1-03

Factors Associated with Use of Active Surveillance in NCCN Favorable Intermediate-Risk Prostate Cancer Patients Who Received a 17-gene Genomic Prostate Score Result
Benjamin Lowentritt, MD, FACS

MP1-04

A Review of SpaceOAR Complications and Influential Patient Characteristics
Erica Mann, MD

MP1-05

Do 5-alpha Reductase Inhibitors Effect the Diagnostic Accuracy of MRI-Fusion Biopsies?
Erica Mann, MD

MP1-06

Comparing MRI/US Fusion to Standard Prostate Biopsy in Determining Grade Reclassification at Confirmatory Biopsy in a Multi-Institutional Active Surveillance Cohort: A Pennsylvania Urology Regional Collaborative (PURC) Analysis
David Strauss, MD

MP1-07

PSA Density is Complementary to Prostate MRI PI-RADS Scoring System for Stratifying Clinically Significant Prostatic Malignancies
James Frisbie, MD

MP1-08

Sagacity of Same Day Discharge: Incidence and Timing of Postoperative Adverse Events Following Minimally Invasive Urologic Surgery
Alberto Castro Bigalli, MD, MS

MP1-09

Financial Toxicity of Prostate Cancer Survivorship: A National Cross-Sectional Assessment of Indirect Financial Burden
Christopher Herrera

MP1-10

Large Scale Implementation of Opioid Prescription Reduction after Robotic Prostatectomy – 2-Year Evaluation from the Pennsylvania Urologic Regional Collaborative (PURC)
Charles Keith

MP1-11

Analyzing Recent Medicare Reimbursement Trends in Urology
Daniel Nemirovsky

MP1-12

Racial and Stage Disparities in Increased Survival Among Patients with Metastatic Prostate Cancer in the Second-Line Antiandrogen Therapy Era
Isaac Kim, Jr., BSc

MP1-13

Gleason Upgrading Between Targeted and Systematic Template Biopsy for mpMRI PIRADS 5 Lesions
Charles Klose, MS

MP1-14

Qualitative Evaluation of Differing Opioid Sparing Protocols Across the Pennsylvania Regional Collaborative: Understanding Barriers and Facilitators
Thenappan Chandrasekar, MD

MP1-15

Existing Urine Exosome Gene Expression Signature to Assess Upgrade Risk on Radical Prostatectomy (RP)
Ronald Tutrone, MD, FACS